3950 Investors following Natco Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Natco Pharma defers buyback schedule
Natco Pharma Ltd (NPL), the Hyderabad-based pharma company that has recently announced its decision to go in for buyback of shares, on Monday informed the stock exchanges that it has now decided to defer the schedule.
Natco Pharma Ltd (NPL), the Hyderabad-based pharma company that has recently announced its decision to go in for buyback of shares, on Monday informed the stock exchanges that it has now decided to defer the schedule.
The buyback schedule was to begin on September 12 and continue either for a year or the funds earmarked were exhausted. The company proposes to buyback its shares of Rs 10 each at a maximum price of Rs 150 per share. It has earmarked funds of Rs 7 crore for the buyback process.
Fulfilling formalities
The company told the stock exchanges that its promoters are now in the process of complying with additional requisite statutory formalities and approvals related to SEBI regulations on substantial acquisition of shares and takeovers.
Though the buyback of shares does not attract SEBI guidelines on substantial acquisition, the company and promoters were advised by the manager to the buyback offer to comply with certain additional statutory formalities, according to the Natco Company Secretary, Mr M. Adinarayana.
Though the buyback of shares does not attract SEBI guidelines on substantial acquisition, the company and promoters were advised by the manager to the buyback offer to comply with certain additional statutory formalities, according to the Natco Company Secretary, Mr M. Adinarayana. 
